Solitary rectal ulcer causing lower gastrointestinal bleeding is extremely rare in children. Rare presentation, non-specific symptoms, insufficient experience, and characteristics mimicking other rectal diseases may cause misdiagnosis or delay of diagnosis in some pediatric patients. Here, we report a 10-year-old boy with solitary rectal ulcer diagnosed two years after onset of the symptoms who responded well to the conservative therapy, including high-fiber diet, laxatives, defecation training, and sucralfate enema.
Acute hemorrhagic rectal ulcer (AHRU) is a rare but potentially life-threatening condition. We present the case of a 74-year-old man who developed sudden massive hematochezia and hypotension during hospitalization for fever of unknown origin. He was known to have alcohol-related liver cirrhosis, hypoalbuminemia and coronary artery disease (CAD) and was on daily aspirin.
Solitary Rectal Ulcer Syndrome (SRUS) is a rare defecation disorder with varied clinical manifestations and often presents challenges in diagnosis. To date, there is no definitive treatment for SRUS. However, there is consensus that treatment should be individualized, multimodal, and focused on addressing potential causes of the disease.
Solitary rectal ulcer syndrome is a rare, chronic, and benign disorder. It can be observed as ulcers in the rectal mucosa, solitary or multiple lesions. It can often be misdiagnosed with other intestinal morbidities, due to its clinical similarities.
Introduction: Solitary rectal ulcer syndrome (SURS) is a poorly understood and uncommon benign disorder of the lower gastrointestinal tract. It presents with various symptoms, often misinterpreted as inflammatory bowel disease. To date, there is no association between the use of selective serotonin reuptake inhibitors (SSRIs) and SURS.
Patients with multiple colorectal cancers (CRC) show distinct clinical characteristics, including a higher prevalence of strong family history and right-sided colon cancer compared to those with solitary CRC.
A study analyzed 1,272 patients, revealing that 7.8% had multiple CRCs, with varying outcomes for synchronous and metachronous cases, particularly in terms of operation time and blood loss.
Overall, minimally invasive surgery (MIS) is feasible for treating multiple CRCs, and recent advancements like indocyanine green fluorescence imaging have improved postoperative outcomes, including reducing anastomotic leakage rates.
